
The role of immunity in the causes of hypertension
High blood pressure is an important modifiable risk factor of morbidity related to cardiovascular diseases. While there are several factors contributing to the causes of hypertension, the role of the immune system has been established firmly during several scientific investigations. It has been found that a healthy immune system could regulate the factors playing a role in the development of hypertension. Similarly, a faulty or weak immune system may increase the risk of developing this condition. Here is a brief discussion about the role of the immune system in the pathogenesis of hypertension.
How does the immune system affect the causes of hypertension?
Inhibition of cytokines
Research studies have indicated that the inhibition of pro-inflammatory agents such as cytokines can reduce the risk of hypertension. It has been found that lymphocytes, one of the forms of immune cells, play a role in the development of hypertension and hypertensive organ injury. Immune reactivity could also be the driving force that contributes to the causes of hypertension in patients with autoimmune diseases. These pathways of pathogenesis are linked to the infiltration of immune cells, as well as oxidative damage, and stimulation of the renin-angiotensin system due to the activation of adaptive and innate immunity. Hence, it is advisable to improve immune system functions to minimize the effect of the dysfunctional vascular relaxation, inflammation-induced impairment in pressure natriuresis relationship, and the hyperactivity of the sympathetic nervous system. Regulation of the immune system may restore the balances between the pro-inflammatory and anti-inflammatory responses of regulatory T cells thereby inhibiting abnormal changes or damage to the vascular system responsible for hypertension.Innate and adaptive immunity
Recent clinical studies have indicated the possible role of the innate and adaptive immunities in triggering the causes of hypertension. Inflammatory cells, such as T cells and macrophages, accumulate in the walls of the blood vessels, specifically in perivascular fat and the kidneys. Also, a lower lymphocyte count has been found to be associated with a resistance to the development of hypertension, while the adoptive transfer of T cells is found to restore the hypertensive response to DOCA-salt and angiotensin II challenges. The results of these studies have suggested that taking steps to improve the functions of the immune system and maintain a controlled production of immune cells could help to inhibit hypertension. The study has further iterated that immune-modulating agents may have a variable intensity of beneficial effects in reducing end-organ damage linked to hypertension. It is believed that the mechanisms by which an abnormal immune response is stimulated in hypertensive patients might involve the formation of neo-antigens, which activate adaptive immunity. Hence, the identification of these neo-antigens and evaluating their role in the activation of adaptive immunity is recommended for the prevention of hypertension.